GI
RGNX icon

GAMMA Investing’s Regenxbio RGNX Stock Holding History

GAMMA Investing’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3K Sell
2,282
-37
-2% -$307 ﹤0.01% 2676
2026
Q1 		$19.4K Buy
2,319
+126
+6% +$1.32K ﹤0.01% 2725
2025
Q4 		$31.6K Buy
2,193
+205
+10% +$2.56K ﹤0.01% 2358
2025
Q3 		$19.2K Sell
1,988
-943
-32% -$8.34K ﹤0.01% 2533
2025
Q2 		$24.1K Buy
2,931
+667
+29% +$5.58K ﹤0.01% 2360
2025
Q1 		$16.2K Sell
2,264
-1,165
-34% -$8.67K ﹤0.01% 2504
2024
Q4 		$26.5K Buy
3,429
+2,510
+273% +$23.6K ﹤0.01% 2112
2024
Q3 		$9.64K Buy
919
+704
+327% +$8.58K ﹤0.01% 2476
2024
Q2 		$2.52K Sell
215
-360
-63% -$5.6K ﹤0.01% 2819
2024
Q1 		$12.1K Buy
575
+510
+785% +$9.07K ﹤0.01% 1950
2023
Q4 		$801 Buy
+65
New +$1.15K ﹤0.01% 2856

Other funds holding RGNX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing's RGNX Position: Q2 2026 in Review

GAMMA Investing reduced its Regenxbio (RGNX) stake by 1.6% in Q2 2026, selling an estimated $307 and leaving 2,282 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

GAMMA Investing first reported a position in RGNX in Q4 2023 and has held it in 11 quarters since. The position peaked at $31.6K in Q4 2025. 14 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • GAMMA Investing held 2,282 shares of Regenxbio worth $27.3K as of Q2 2026.
  • GAMMA Investing sold 37 Regenxbio shares in Q2 2026, an estimated $307.
  • Regenxbio made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2676 holding.
  • GAMMA Investing first reported a position in Regenxbio in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Regenxbio position peaked at $31.6K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.